Research Papers:

Baicalein inhibits pancreatic cancer cell proliferation and invasion via suppression of NEDD9 expression and its downstream Akt and ERK signaling pathways

Rong-Tao Zhou, Mei He, Ze Yu, Yang Liang, Yuzhe Nie, Sheng Tai and Chun-Bo Teng _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:56351-56363. https://doi.org/10.18632/oncotarget.16912

Metrics: PDF 2689 views  |   HTML 4052 views  |   ?  


Rong-Tao Zhou1, Mei He1, Ze Yu1, Yang Liang1, Yuzhe Nie1, Sheng Tai2 and Chun-Bo Teng1

1College of Life Science, Northeast Forestry University, Harbin, China

2Department of General Surgery, The Second Hospital of Harbin Medical University, Harbin, China

Correspondence to:

Chun-Bo Teng, email: [email protected]

Keywords: baicalein, pancreatic cancer, NEDD9, Akt, ERK

Received: December 21, 2016    Accepted: March 06, 2017    Published: April 07, 2017


Baicalein, a flavone ingredient of Scutellaria baicalensis Georgi, is a promising anti-cancer agent. However, its potential anti-pancreatic cancer effects and the underlying mechanisms are still unclear. In this study, we showed that Baicalein not only induced apoptosis, but also suppressed proliferation, migration and invasion of two pancreatic cancer cell lines BxPC-3 and PANC-1 in a dose- and time-dependent manner. Notably, Baicalein exhibited low toxicity to normal human liver or kidney cells. We further discovered that Baicalein suppressed BxPC-3 and PANC-1 cell proliferation and invasion through targeting the expression of NEDD9, a Cas scaffolding protein, to decrease Akt and ERK activities. Especially, Baicalein decreased Akt phosphorylation at T-308 via lowering NEDD9-dependent PDK1 expression. Overexpression of NEDD9 effectively rescued proliferation and invasion of BxPC-3 and PANC-1 cells dampened by Baicalein. Taken together, our findings suggest that Baicalein is a potent remedy applied to pancreatic cancer treatment in the future.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 16912